Beta Drugs Limited (NSE:BETA)

Beta Drugs Revenue

Beta Drugs had revenue of 1.80B INR in the half year ending September 30, 2024, with 60.43% growth. This brings the company's revenue in the last twelve months to 3.35B, up 30.77% year-over-year. In the fiscal year ending March 31, 2024, Beta Drugs had annual revenue of 2.96B with 30.21% growth.

• Revenue (ttm): 3.35B
• Revenue Growth: +30.77%
• P/S Ratio: 4.85
• Revenue / Employee: 9.02M
• Employees: 371
• Market Cap: 16.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	2.96B	686.00M	30.21%
Mar 31, 2023	2.27B	432.76M	23.54%
Mar 31, 2022	1.84B	677.16M	58.31%
Mar 31, 2021	1.16B	253.16M	27.88%
Mar 31, 2020	908.06M	248.77M	37.73%